Results 181 to 190 of about 80,369 (215)

Multidrug-resistant tuberculosis

Infectious Disease Clinics of North America, 2002
Multidrug-resistant TB is a growing public health problem. Although control of the multidrug-resistant TB epidemic has been achieved in New York City, strains of multidrug-resistant TB are found in nearly every state. Much of the world faces a growing problem with no immediate solution.
openaire   +2 more sources

Confronting Multidrug-Resistant Tuberculosis

New England Journal of Medicine, 2012
Microbial resistance to antituberculosis drugs has existed since the dawn of the antibiotic era.1 Multidrug-resistant (MDR) tuberculosis, defined by resistance to isoniazid and rifampin, requires treatment for up to 2 years with expensive second-line drugs that have poor side-effect profiles; success rates rarely exceed 65 to 75%.
Richard E, Chaisson, Eric L, Nuermberger
openaire   +2 more sources

Multidrug-Resistant Tuberculosis Spondylitis

Acta Clinica Belgica, 2000
We report a case of multidrug-resistant spinal tuberculosis complicated by epiduritis and paraspinal abscess in a 68-year-old black woman. Multidrug-resistant tuberculous spondylitis is still rare in Belgium. Two others cases were reported from 1992 to 1997.
Cherifi, Soraya, Guillaume, Marie-Paule, Peretz, Anne   +2 more
openaire   +2 more sources

Management of Multidrug-Resistant Tuberculosis

Seminars in Respiratory and Critical Care Medicine, 2013
AbstractDrug-resistant strains of Mycobacterium tuberculosis pose a major threat to global tuberculosis control. Despite the availability of curative antituberculosis therapy for nearly half a century, inappropriate and inadequate treatment of tuberculosis, as well as unchecked transmission of M.
Charles L, Daley, Jose A, Caminero
openaire   +3 more sources

Multidrug-Resistant Tuberculosis

New England Journal of Medicine, 1992
Excerpt As recently as 10 years ago, tuberculosis was rapidly disappearing from the United States.
Samuel W. Dooley, William R. Jarvis, William J. Marione, Dixie E. Snider   +3 more
openaire   +2 more sources

Multidrug-resistant tuberculosis

2014
Abstract Multidrug-resistant tuberculosis (MDR-TB) is increasingly being identified around the world. Treatment options are limited due to the lack of new anti-mycobacterial agents and the side-effect profiles of currently available options.
Caoimhe Nic Fhogartaigh, Mike Brown
openaire   +1 more source

[Multidrug-resistant tuberculosis].

Presse medicale (Paris, France : 1983), 1996
The quality of diagnosis and therapeutic management affects the frequency of multiresistant tuberculosis observed in a given country. In 1991, physicians in the United States were faced with a large number of cases of multiresistant tuberculosis in patients with acquired immune deficiency syndrome, leading to international public health measures ...
openaire   +3 more sources

Multidrug resistant tuberculosis

Pathology, 2011
Multidrug resistant tuberculosis (MDRTB) and extensively resistant TB (XDRTB) are an increasing problem worldwide, especially in resource-poor nations. MDRTB is associated with vastly increased therapeutic costs and increased treatment failure rates.
openaire   +1 more source

Multidrug-Resistant Tuberculosis

Infectious Diseases in Clinical Practice, 1997
Jonathan Shuter, Eran Bellin
  +4 more sources

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly